Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 98.
4. lappuse
... Penicillin antibiotic drugs 483 441 Penem antibiotic drugs 588 442 Cepha antibiotic drugs 593 443 Carbacephem antibiotic drugs 696 444 Oligosaccharide antibiotic drugs 699 446 Tetracycline antibiotic drugs 761 448 Peptide antibiotic ...
... Penicillin antibiotic drugs 483 441 Penem antibiotic drugs 588 442 Cepha antibiotic drugs 593 443 Carbacephem antibiotic drugs 696 444 Oligosaccharide antibiotic drugs 699 446 Tetracycline antibiotic drugs 761 448 Peptide antibiotic ...
172. lappuse
... penicillin , streptomycin , chlortetra- cycline , chloramphenicol , bacitracin , or any other antibiotic drug , or any de- rivative thereof , intended for human use and no existing regulation will be continued in effect unless it is ...
... penicillin , streptomycin , chlortetra- cycline , chloramphenicol , bacitracin , or any other antibiotic drug , or any de- rivative thereof , intended for human use and no existing regulation will be continued in effect unless it is ...
310. lappuse
... penicillin F , penicillin G , penicillin X ) produced by the growth of Penicillium notatum or Penicillium chrysogenum , and each of the same substances produced by any other means , is 310 § 429.60 21 CFR Ch . I ( 4-1-98 Edition ) ...
... penicillin F , penicillin G , penicillin X ) produced by the growth of Penicillium notatum or Penicillium chrysogenum , and each of the same substances produced by any other means , is 310 § 429.60 21 CFR Ch . I ( 4-1-98 Edition ) ...
311. lappuse
... penicillin . ( 2 ) Streptomycin . Each of the several antibiotic substances produced by the growth of Streptomyces griseus , and each of the same substances produced by any other means , is a kind of strepto- mycin . ( 3 ) ...
... penicillin . ( 2 ) Streptomycin . Each of the several antibiotic substances produced by the growth of Streptomyces griseus , and each of the same substances produced by any other means , is a kind of strepto- mycin . ( 3 ) ...
314. lappuse
... penicillin- ( i ) Penicillin G The term " penicillin G master standard ' means a specific lot of crystalline peni- cillin G that is designated by the Com- missioner as the standard of compari- son in determining the potency of the ...
... penicillin- ( i ) Penicillin G The term " penicillin G master standard ' means a specific lot of crystalline peni- cillin G that is designated by the Com- missioner as the standard of compari- son in determining the potency of the ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning